Medical Digest & Congress Report

Professor Ann Partridge shares his thoughts on breast cancer, early stage highlights of the ESMO 2024 Congress.

Video: https://medicaldigest.org/scientific-contents/interview:breast-cancer-early-stage-highlights-esmo-2024-congress

Professor Remi Nout shares his thoughts on the interim results of the phase 3 ENGOT-en11/GOG-3053/KEYNOTE-B21 trial that were presented during the ESMO Congress 2024.

Video: https://medicaldigest.org/scientific-contents/interview:adjuvant-pembrolizumabchemotherapy-misses-dfs-end-point-high-risk-endometrial-cancer-benefits-dmmr-subgroup

Professor Remi Nout shares his thoughts on the treatment of cervical cancer in 2024 in the light of KEYNOTE-A18 study.

Video: https://medicaldigest.org/scientific-contents/interview:treatment-cervical-cancer-2024-highlight-keynote-a18-study

Prof. Michael Böhm explains how SGLT-2 inhibitors became a strong pillar of treatment in HFrEF and HFpEF patients. Their antidiabetic effect and kidney protection make them a widely used tool in cardiovascular diseases. We learn where GLP-1 agonists stand in cardiovascular risk protection and how beneficial they are in overweight HFpEF patients. The new mineralocorticoid receptor antagonists (MRAs) also proved their role in HF treatment. The new, non-steroid MRA, finerenone improved CV outcomes in the FINEARTS-HF trial in HFpEF patients, presented at ESC2024. The MOONRAKER program will further investigate finerenone’s place in HF therapy. He stresses that we must use all 4 pillars of HF treatment.

Video: https://medicaldigest.org/scientific-contents/interview:new-pillars-optimal-medical-treatment-heart-failure

Prof. Carlos Robalo Cordeiro, immediate Past-President of the ERS shares his thoughts on the highlights of ERS 2024.

Video: https://medicaldigest.org/scientific-contents/interview:highlihts-ers-2024-presidents-perspective

Prof. Michael Kreuter co-chaired a very interesting session at this years ERS congress on novelties in the treatement of interstitial lung diseases and pulmonary fibrosis.

Video: https://medicaldigest.org/scientific-contents/interview:why-idiopathic-pulmonary-fibrosis-not-so-idiopathic-report-ers2024

Prof. Joan B. Soriano co-chaired a very interesting session at this years ERS congress on the challenges of increasing urbanisation for respiratory health and how to improve it in the 21st century.

Video: https://medicaldigest.org/scientific-contents/interview:imroving-lung-health-21s-century

Prof. Ane Johannessen co-chaired an interesting session to identify how future city life around the world may have the potential to improve respiratory health.

Video: https://medicaldigest.org/scientific-contents/interview:overcoming-challenges-increasing-urbanisation-respiratory-health

Prof. Maria Joana Pereira Catarata co-chaired a very interesting session on lung cancer diagnostics and treatment challenges.

Video: https://medicaldigest.org/scientific-contents/interview:thoracic-oncology-lung-cancer-diagnostics-and-treatment-challenges

Prof. Charlotte Suppli Ulrik co-chaired a very interesting session at this years ERS congress on novel research data on asthma and chronic obstructive pulmonary disease management.

Video: https://medicaldigest.org/scientific-contents/interview:novel-research-data-asthma-and-chronic-obstructive-pulmonary-disease-management-clinical-applications